GSK2798745, efficacy, safety, chronic cough, crossover study
Showing 26 - 50 of >10,000
Pulmonary Disease, Chronic Obstructive Trial in Canada, Denmark (GSK2269557, Placebo, DISKUS)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK2269557
- +3 more
-
Vancouver, British Columbia, Canada
- +5 more
Aug 12, 2021
Refractory and/or Unexplained Chronic Cough Trial in Worldwide (BAY1817080, Placebo)
Completed
- Refractory and/or Unexplained Chronic Cough
- BAY1817080
- Placebo
-
Los Angeles, California
- +98 more
Jul 24, 2022
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK2269557, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK2269557
- Placebo
-
Edegem, Belgium
- +16 more
Aug 11, 2021
Refractory Chronic Cough Trial in United Kingdom, United States (5 mg Serlopitant Tablets, Matching Placebo Tablets)
Completed
- Refractory Chronic Cough
- 5 mg Serlopitant Tablets
- Matching Placebo Tablets
-
Los Angeles, California
- +38 more
May 18, 2021
Anaemia, Aspergillosis, Allergic Bronchopulmonary Trial in Worldwide (Daprodustat, rhEPO, Placebo)
Completed
- Anaemia
- Aspergillosis, Allergic Bronchopulmonary
- Daprodustat
- +3 more
-
Huntsville, Alabama
- +461 more
Nov 5, 2021
COPD (COPD) Trial in Germany (BFF, Symbicort Turbuhaler)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- BFF
- Symbicort Turbuhaler
-
Frankfurt/Main, Germany
- +3 more
Feb 21, 2022
Anaemia Trial in Worldwide (Daprodustat (GSK1278863), Placebo, Iron therapy)
Completed
- Anaemia
- Daprodustat (GSK1278863)
- +2 more
-
Homewood, Alabama
- +167 more
Oct 5, 2021
Idiopathic Pulmonary Fibrosis, Cough Trial in India (ME-015 (Suplatast Tosilate), Identical )
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Cough
- ME-015 (Suplatast Tosilate)
- Identical placebo
-
Guntur, Andhra Pradesh, India
- +3 more
Aug 1, 2023
Refractory Chronic Cough Trial (Gefapixant, Placebo (for gefapixant))
Completed
- Refractory Chronic Cough
- Gefapixant
- Placebo (for gefapixant)
- (no location specified)
Jun 17, 2020
Chronic Cough Trial in Parkville (Gefapixant)
Not yet recruiting
- Chronic Cough
-
Parkville, Victoria, AustraliaThe University of Melbourne
Apr 18, 2023
COPD Trial in Russian Federation (Rengalin, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Rengalin
- Placebo
-
Barnaul, Russian Federation
- +17 more
Nov 17, 2020
Lung Cancer, Nonsmall Cell, Perioperative, Cough Trial (Breztri Aerosphere, Placebo)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- +4 more
- Breztri Aerosphere
- Placebo
- (no location specified)
Jul 22, 2022
Anaemia Trial in Japan (1 to 4 mg tablets of GSK1278863, 6 mg GSK1278863 tablet, Epoetin beta pegol)
Completed
- Anaemia
- 1 to 4 mg tablets of GSK1278863
- +2 more
-
Aichi, Japan
- +55 more
Apr 27, 2021
COPD Trial in Worldwide (CHF 5259, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- CHF 5259
- Placebo
-
Sevlievo, Bulgaria
- +28 more
Oct 28, 2021
Chronic Spontaneous Urticaria Trial in Germany, Poland, United States (LY3454738, Placebo)
Terminated
- Chronic Spontaneous Urticaria
- LY3454738
- Placebo
-
Bakersfield, California
- +24 more
Feb 14, 2022